These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21210170)

  • 21. Oral candidiasis and angular cheilitis.
    Sharon V; Fazel N
    Dermatol Ther; 2010; 23(3):230-42. PubMed ID: 20597942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gentian violet treatment for thrush: can its use cause breastfeeding problems?
    Utter AR
    J Hum Lact; 1990 Dec; 6(4):178-80. PubMed ID: 2271112
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of oral candidiasis in HIV infection.
    Greenspan D
    Oral Surg Oral Med Oral Pathol; 1994 Aug; 78(2):211-5. PubMed ID: 7936591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjunctival staining and corneal and conjunctival abrasions caused by 2% aqueous gentian violet solution.
    Pessah A; Ofosu JR; Klein BL
    Pediatr Emerg Care; 1998 Aug; 14(4):285-6. PubMed ID: 9733255
    [No Abstract]   [Full Text] [Related]  

  • 25. Is gentian violet safe?
    Phillips V
    J Hum Lact; 1993 Mar; 9(1):7-8. PubMed ID: 8489730
    [No Abstract]   [Full Text] [Related]  

  • 26. Gentian violet toxicity.
    Piatt JP; Bergeson PS
    Clin Pediatr (Phila); 1992 Dec; 31(12):756-7. PubMed ID: 1451385
    [No Abstract]   [Full Text] [Related]  

  • 27. Gentian violet and thrush.
    Utter AR
    J Hum Lact; 1992 Mar; 8(1):6. PubMed ID: 1558661
    [No Abstract]   [Full Text] [Related]  

  • 28. Letter: Oral irritation with gentian violet.
    Horsfield P; Logan FA; Newey JA
    Br Med J; 1976 Aug; 2(6034):529. PubMed ID: 953673
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics.
    Schmidt-Westhausen AM; Bendick C; Reichart PA; Samaranayake LP
    Mycoses; 2004 Oct; 47(9-10):435-41. PubMed ID: 15504130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posaconazole for the management of mucosal candidiasis.
    Vazquez JA
    Future Microbiol; 2007 Jun; 2(3):245-56. PubMed ID: 17661697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal violet stain as a selective stain for the assessment of mitotic figures in oral epithelial dysplasia and oral squamous cell carcinoma.
    Jadhav KB; Ahmed Mujib BR; Gupta N
    Indian J Pathol Microbiol; 2012; 55(3):283-7. PubMed ID: 23032818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.
    Groll AH; Wood L; Roden M; Mickiene D; Chiou CC; Townley E; Dad L; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2554-63. PubMed ID: 12121932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida infection of the tongue.
    Yassin A; Mostafa MA; Moawad MK
    J Laryngol Otol; 1966 Feb; 80(2):138-50. PubMed ID: 5905548
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of efficacy of 1% Crystal Violet & Nuclear Fast Red stain compared to Haematoxyline & Eosin stain for assessing mitotic figures in oral premalignant and malignant lesions.
    Motiwale G; Jaiswal S; Vikey A; Motiwale T; Bagulkar B; Bhat A; Kapoor P
    J Exp Ther Oncol; 2016 Jul; 11(3):165-170. PubMed ID: 28471120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antifungal drug susceptibility of Candida causing oropharyngeal candidiasis in HIV infected patients].
    Dieng Y; Faye-Niang MA; Ndour-Diop A; Sow PS; Dieng T; Soumare M; Bah IB; Faye O; Diop BM; Gaye O; Ndir O; Diallo S
    Dakar Med; 2001; 46(1):4-7. PubMed ID: 15773146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients.
    Murray PA; Koletar SL; Mallegol I; Wu J; Moskovitz BL
    Clin Ther; 1997; 19(3):471-80. PubMed ID: 9220211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.